Ligand Pharmaceuticals Incorporated (LGND)

Ligand Pharmaceuticals Revenue

Ligand Pharmaceuticals had revenue of $51.81M in the quarter ending September 30, 2024, with 57.64% growth. This brings the company's revenue in the last twelve months to $152.42M, down -0.76% year-over-year. In the year 2023, Ligand Pharmaceuticals had annual revenue of $131.31M, down -33.09%.

• Revenue (ttm): $152.42M
• Revenue Growth: -0.76%
• P/S Ratio: 13.11
• Revenue / Employee: $2,627,966
• Employees: 58
• Market Cap: 2.21B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	131.31M	-64.93M	-33.09%
Dec 31, 2022	196.25M	-45.30M	-18.75%
Dec 31, 2021	241.54M	77.98M	47.68%
Dec 31, 2020	163.56M	43.28M	35.98%
Dec 31, 2019	120.28M	-131.17M	-52.17%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.